These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 36300247)

  • 1. Psychosis and psychedelics: Historical entanglements and contemporary contrasts.
    Friesen P
    Transcult Psychiatry; 2022 Oct; 59(5):592-609. PubMed ID: 36300247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture.
    Hartogsohn I
    Transcult Psychiatry; 2022 Oct; 59(5):579-591. PubMed ID: 35818775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The History of Psychedelics in Psychiatry.
    Nichols DE; Walter H
    Pharmacopsychiatry; 2021 Jul; 54(4):151-166. PubMed ID: 33285579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.
    Wießner I; Falchi M; Palhano-Fontes F; Feilding A; Ribeiro S; Tófoli LF
    Psychol Med; 2023 Mar; 53(4):1151-1165. PubMed ID: 34253268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis.
    Dourron HM; Strauss C; Hendricks PS
    Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bodily self from psychosis to psychedelics.
    Harduf A; Panishev G; Harel EV; Stern Y; Salomon R
    Sci Rep; 2023 Dec; 13(1):21209. PubMed ID: 38040825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms.
    Tariq R
    Curr Rev Clin Exp Pharmacol; 2023; 18(2):94-109. PubMed ID: 35319407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History, rationale and potential of human experimental hallucinogenic drug research in psychiatry.
    Gouzoulis-Mayfrank E; Hermle L; Thelen B; Sass H
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():63-8. PubMed ID: 9754835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20
    Aday JS; Bloesch EK; Davoli CC
    J Psychoactive Drugs; 2019; 51(3):210-217. PubMed ID: 30836890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shamans, sacraments, and psychiatrists.
    Bravo G; Grob C
    J Psychoactive Drugs; 1989; 21(1):123-8. PubMed ID: 2656948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why psychiatry needs psychedelics and psychedelics need psychiatry.
    Sessa B
    J Psychoactive Drugs; 2014; 46(1):57-62. PubMed ID: 24830186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.
    Hendricks PS
    Int Rev Psychiatry; 2018 Aug; 30(4):331-342. PubMed ID: 30260256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelic-assisted therapies: The past, and the need to move forward responsibly.
    Gardner J; Carter A; O'Brien K; Seear K
    Int J Drug Policy; 2019 Aug; 70():94-98. PubMed ID: 31136924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Past and Future of Psychedelic Science: An Introduction to This Issue.
    Doblin RE; Christiansen M; Jerome L; Burge B
    J Psychoactive Drugs; 2019; 51(2):93-97. PubMed ID: 31132970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience.
    Neitzke-Spruill L; Glasser C
    J Psychoactive Drugs; 2018; 50(4):314-321. PubMed ID: 30052496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.
    Holoyda B
    Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives.
    Jachimowski A; Kucia K
    Psychiatr Pol; 2023 Jun; 57(3):657-670. PubMed ID: 38043078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).
    Nour MM; Evans L; Nutt D; Carhart-Harris RL
    Front Hum Neurosci; 2016; 10():269. PubMed ID: 27378878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.